The cellular imaging core will provide three major services to all four of the projects in this PPG including comprehensive: 1) functional analysis of cardiac cells in wild-type and genetically modified mice 2) ultrastructural analysis of cardiac cells in wild-type and genetically modified mice and 3) evaluation of apoptosis in myocardial tissue. Functional cellular analysis includes: A) Enzymatic isolation and electrical-field stimulated culture of murine adult ventricular cardiomyocytes (VCs) B) Assessment of in vitro contractile function of VCs using a digitalized video-edge detection system C) Analysis of in vitro cellular calcium (Ca2+) transients in VCs using the fluorescent calcium indicator FURA2-AM. Ultra-structural cellular analysis includes: A) Immunofluorescent confocal microscopy of VCs B) Immunofluorescent and immunohistological microscopic analysis of myocardial tissue C) Epifluorescent analysis of VC morphology Apoptosis evaluation includes: A) Terminal deoxynucleotidyl-transferase mediated dUTP nick end (TUNEL) labeling and related imaging in myocardial sections B) Caspase-3 activity in myocardial extracts C) Hairpin 1 (apoptosis) and Hairpin 2 (necrosis) D) Cardiac Myosin Heavy Chain imaging The laboratories of the Core Co-Directors have considerable experience in a wide-ranging array of methodologies for functional and ultra-structural cellular imaging. In particular, isolation and maintenance of high-quality murine VCs is a crucial prerequisite for subsequent functional and ultra-structural analysis. An enzymatic isolation procedure yielding more than 90% viable VCs has been established by Core Co-Directors and is combined with a low-frequent field-stimulated culture system preventing functional and structural dedifferentiation such as the disintegration of the T-tubular system with subsequent loss of cellular excitability. This innovative approach will enable us to investigate VCs from the same heart in a functional and ultra-structural manner.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
7P01HL091799-05
Application #
8378711
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
2014-05-31
Budget Start
2012-06-04
Budget End
2013-05-31
Support Year
5
Fiscal Year
2012
Total Cost
$184,440
Indirect Cost
$63,891
Name
Temple University
Department
Type
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
de Lucia, Claudio; Gambino, Giuseppina; Petraglia, Laura et al. (2018) Long-Term Caloric Restriction Improves Cardiac Function, Remodeling, Adrenergic Responsiveness, and Sympathetic Innervation in a Model of Postischemic Heart Failure. Circ Heart Fail 11:e004153
Tahrir, Farzaneh G; Shanmughapriya, Santhanam; Ahooyi, Taha Mohseni et al. (2018) Dysregulation of mitochondrial bioenergetics and quality control by HIV-1 Tat in cardiomyocytes. J Cell Physiol 233:748-758
Myers, Valerie D; McClung, Joseph M; Wang, JuFang et al. (2018) The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease. JACC Basic Transl Sci 3:122-131
Myers, Valerie D; Tomar, Dhanendra; Madesh, Muniswamy et al. (2018) Haplo-insufficiency of Bcl2-associated athanogene 3 in mice results in progressive left ventricular dysfunction, ?-adrenergic insensitivity, and increased apoptosis. J Cell Physiol 233:6319-6326
Borghetti, Giulia; von Lewinski, Dirk; Eaton, Deborah M et al. (2018) Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control. Front Physiol 9:1514
Grisanti, Laurel A; Schumacher, Sarah M; Tilley, Douglas G et al. (2018) Designer Approaches for G Protein-Coupled Receptor Modulation for Cardiovascular Disease. JACC Basic Transl Sci 3:550-562
de Lucia, Claudio; Eguchi, Akito; Koch, Walter J (2018) New Insights in Cardiac ?-Adrenergic Signaling During Heart Failure and Aging. Front Pharmacol 9:904
Grisanti, Laurel A; Thomas, Toby P; Carter, Rhonda L et al. (2018) Pepducin-mediated cardioprotection via ?-arrestin-biased ?2-adrenergic receptor-specific signaling. Theranostics 8:4664-4678
Cannavo, Alessandro; Koch, Walter J (2018) GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease. Cell Signal 41:33-40
Yeh, Szu-Tsen; Zambrano, Cristina M; Koch, Walter J et al. (2018) PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy in vitro. J Biol Chem 293:8056-8064

Showing the most recent 10 out of 163 publications